Proposed Data Collection Submitted for Public Comment and Recommendations, 74106-74108 [2015-30130]
Download as PDF
74106
Federal Register / Vol. 80, No. 228 / Friday, November 27, 2015 / Notices
description applicable to the supplies.
The Government will use these
descriptions as well as other
information available to determine the
classification description most
appropriate and advantageous to the
government.
A. Purpose
mstockstill on DSK4VPTVN1PROD with NOTICES
• Regulations.gov: https://
www.regulations.gov.
Submit comments via the Federal
eRulemaking portal by searching the
OMB control number. Select the link
‘‘Submit a Comment’’ that corresponds
with ‘‘Information Collection 9000–
0055, Freight Classification
Description’’. Follow the instructions
provided at the ‘‘Submit a Comment’’
screen. Please include your name,
company name (if any), and
‘‘Information Collection 9000–0055,
Freight Classification Description’’ on
your attached document.
• Mail: General Services
Administration, Regulatory Secretariat
Division (MVCB), 1800 First Street NW.,
Washington, DC 20405. ATTN: Ms.
Flowers/IC 9000–0055, Freight
Classification Description.
Instructions: Please submit comments
only and cite Information Collection
9000–0055, Freight Classification
Description, in all correspondence
related to this collection. Comments
received generally will be posted
without change to https://
www.regulations.gov, including any
personal and/or business confidential
information provided. To confirm
receipt of your comment(s), please
check www.regulations.gov,
approximately two to three days after
submission to verify posting (except
allow 30 days for posting of comments
submitted by mail).
FOR FURTHER INFORMATION CONTACT: Mr.
Curtis E. Glover, Sr., Procurement
Analyst, Office of Acquisition Policy, at
202–501–1448 or via email at
curtis.glover@gsa.gov.
SUPPLEMENTARY INFORMATION:
Edward Loeb,
Acting Director, Office of Governmentwide
Acquisition Policy, Office of Acquisition
Policy, Office of Governmentwide Policy.
The Government is required to
provide, in solicitations, a complete
description of the supplies to be
acquired and the packing requirements
to determine transportation (freight rate)
charges for the evaluation of offers.
Generally, the freight rate for supplies is
based on the ratings applicable to the
freight classification description
published in the National Motor Freight
Classification (for carriers) and the
Uniform Freight Classification (for rail)
filed with Federal and State regulatory
bodies.
When the Government purchases
supplies that are new to the supply
system, nonstandard, or modifications
of previously shipped supplies, and
different freight classifications may
apply, per FAR clause 52.247–53,
offerors are requested to indicate the full
Uniform Freight Classification or
National Motor Freight Classification
VerDate Sep<11>2014
19:01 Nov 25, 2015
Jkt 238001
B. Annual Reporting Burden
Respondents: 3,000.
Responses per Respondent: 3.
Annual Responses: 9,000.
Hours per Response: .167.
Total Burden Hours: 1,503.
C. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary for the proper
performance of functions of the Federal
Acquisition Regulations (FAR), and
whether it will have practical utility;
whether our estimate of the public
burden of this collection of information
is accurate, and based on valid
assumptions and methodology; ways to
enhance the quality, utility, and clarity
of the information to be collected; and
ways in which we can minimize the
burden of the collection of information
on those who are to respond, through
the use of appropriate technological
collection techniques or other forms of
information technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 First Street NW., Washington, DC
20405, telephone 202–501–4755.
Please cite OMB Control No. 9000–
0055, Freight Classification Description,
in all correspondence.
[FR Doc. 2015–30141 Filed 11–25–15; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–16ET; Docket No. CDC–2015–
0107]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled
‘‘Comprehensive HIV Prevention and
Care for Men Who Have Sex with Men
of Color.’’ Seven U.S. health
departments will form, lead, and
coordinate a collaborative with 37
community-based organizations (CBOs),
clinics and other health providers,
behavioral health and social health
providers in their jurisdictions. The
collaborative will report standardized
program monitoring and evaluation
(M&E) data to the health department
and then the health department will
report the same M&E data to CDC.
DATES: Written comments must be
received on or before January 26, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0107 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\27NON1.SGM
27NON1
Federal Register / Vol. 80, No. 228 / Friday, November 27, 2015 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Comprehensive HIV Prevention and
Care for Men Who Have Sex With Men
of Color—New—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Approximately 50,000 people in the
United States are newly infected with
HIV each year. Gay, bisexual, and other
men who have sex with men (MSM)
remain the US population most heavily
affected by HIV infection. Among MSM,
VerDate Sep<11>2014
19:01 Nov 25, 2015
Jkt 238001
those who are black and Hispanic
comprise 58% of all new infections. To
address the burden of HIV in this
population, high impact HIV prevention
approaches should be implemented by
state, local, and territorial health
departments to reduce new HIV
infections among MSM of color, and to
improve outcomes along the HIV
continuum of care for MSM of color
living with HIV.
Antiretroviral (ARV) medications for
pre-exposure prophylaxis (PrEP) can be
used for HIV prevention by MSM at
substantial risk for HIV acquisition or by
those with a possible HIV exposure in
the past 72 hours post-exposure
prophylaxis (nPEP). The daily use of coformulated tenofovir disoproxil
fumarate and emtricitabine (marketed as
Truvada) for PrEP has been proven to
significantly reduce the risk of HIV
acquisition among sexually active MSM.
In July 2012, the US Food and Drug
Administration approved an HIV
prevention indication for Truvada, and
in May 2014 CDC published clinical
practice guidelines for provision of
PrEP. Given the high incidence of HIV
among MSM of color, those who are
sexually active are considered at risk for
HIV acquisition and thus could benefit
from prevention services such as routine
and frequent HIV screening with labbased 4th generation HIV tests, routine
screening for STDs, assessment of PrEP
eligibility, provision of PrEP (if at
substantial risk for HIV acquisition),
provision of nPEP (if a possible HIV
exposure occurred in the past 72 hours),
and/or other risk reduction
interventions.
Among people living with HIV
(PLWH), ARV treatment can suppress
HIV viral load, which both improves
health outcomes of individuals and
reduces the risk of HIV transmission.
Two studies, one that demonstrated the
effectiveness of ARV treatment in
preventing HIV transmission, and one
that demonstrated improved health
outcomes for individuals whose ARV
treatment was initiated immediately,
have led to increased public health
focus on interventions and strategies
designed to initiate ARV treatment, link,
retain, and re-engage PLWH in HIV care,
and to provide support for adherence to
ARV medications.
The purpose of this project is to
support state and local health
departments to develop and implement
demonstration projects for provision of
comprehensive HIV prevention and care
services for MSM of color by creating a
collaborative with CBOs, clinics and
other health care providers, and
behavioral health and social services
providers in their jurisdiction.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
74107
Behavioral health services include
mental health and substance abuse
treatment to enable MSM of color to
utilize HIV prevention and care
services; social services include services
that promote access to housing, job
counseling, and employment services to
enable MSM of color to utilize HIV
prevention and care services.
Comprehensive models of HIV
prevention and care for MSM of color
will be developed and implemented by
a collaborative that is led by the
jurisdiction’s health department and
includes the following: Health care
providers (e.g., federally qualified
health centers (FQHCs), FQHC LookAlikes, other clinics, or health care
providers); HIV care providers (e.g.,
clinics funded through the Ryan White
HIV/AIDS Program (RWHAP clinics),
other HIV care clinics, or HIV care
providers); behavioral health and social
services providers (i.e., mental health
and substance abuse services, housing
programs, and job training or
employment services); and community
based organizations (CBOs). Principles
of high impact prevention should guide
the selection and implementation of
activities and strategies to focus on
MSM of color at substantial risk for HIV
infection (i.e., eligible for prevention
with PrEP), and those living with HIV.
MSM of color who are at risk for HIV
acquisition (i.e., sexually active) but not
eligible for or decline PrEP will be
provided risk reduction interventions,
partner services if diagnosed with an
STD, re-testing for HIV and STDs in 3–
6 months, and behavioral health and
social services. The risk of HIV
acquisition should be assessed at every
encounter with an individual, and MSM
of color at substantial risk of HIV
acquisition should be offered PrEP
when indicated by the risk assessment.
There are a total of 24 required HIV
prevention and care services that must
be provided by the health department
collaborative for this project. This is to
include thirteen HIV prevention
services for MSM of color at substantial
risk for HIV infection and eleven HIV
care services for MSM of color living
with HIV infection. The following are
the thirteen HIV prevention services: 1.
HIV testing services that use lab-based
4th generation HIV tests; 2. Assessment
of indications for pre-exposure
prophylaxis (PrEP) and nonoccupational post- exposure
prophylaxis (nPEP); 3. Provision of PrEP
and nPEP; 4. Adherence interventions
for PrEP and nPEP; 5. Immediate linkage
to care, ARV treatment, and partner
services for those diagnosed with acute
HIV infection; 6. Expedient linkage to
care, ARV treatment, and partner
E:\FR\FM\27NON1.SGM
27NON1
74108
Federal Register / Vol. 80, No. 228 / Friday, November 27, 2015 / Notices
services for those diagnosed with
established HIV infection; 7. STD
screening and treatment; 8. Partner
services for patients with STDs; 9.
Behavioral risk reduction interventions;
10. Screening for behavioral health and
social services’ needs; 11. Linkage to
behavioral health and social services;
12. Navigators to assist accessing HIV
prevention and behavioral health and
social services; 13. Navigators to assist
enrollment in a health plan. The
following are the eleven HIV care
services: 1. HIV primary care, including
antiretroviral (ARV) treatment; 2.
Retention interventions; 3. Reengagement interventions; 4. Adherence
interventions; 5. STD screening and
treatment; 6. Partner services; 7.
Behavioral risk reduction interventions;
8. Screening patients for behavioral
health and social services’ needs; 9.
Linkage to behavioral health and social
services; 10. Navigators to assist linking
to care and accessing behavioral health
and social services; 11. Navigators to
assist enrollment in a health plan.
CDC HIV program grantees will
collect, enter or upload, and report
agency-identifying information, budget
data, information on the HIV prevention
and care services, and client
demographic characteristics with an
estimate of 2,466 burden hours. It is
estimated that the 37 respondents will
see approximately 200 patients per year.
The respondents will take about 20
minutes to enter the data for each of the
200 patients using the monitoring and
evaluation form.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Health jurisdictions ............................
Health Department Collaborative .....
37
200
20/60
2,466
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–30130 Filed 11–25–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–16FE; Docket No. CDC–2015–
0108]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection entitled ‘‘Monitoring and
Reporting System for Rape Prevention
and Education (RPE) Awardees.’’ CDC
will use the information collected to
monitor cooperative agreement
awardees and to identify challenges to
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:01 Nov 25, 2015
Jkt 238001
program implementation and
achievement of outcomes.
DATES: Written comments must be
received on or before January 26, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0108 by any of the following methods:
Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
MS—D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS—D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
E:\FR\FM\27NON1.SGM
27NON1
Agencies
[Federal Register Volume 80, Number 228 (Friday, November 27, 2015)]
[Notices]
[Pages 74106-74108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30130]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-16-16ET; Docket No. CDC-2015-0107]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project entitled ``Comprehensive HIV Prevention
and Care for Men Who Have Sex with Men of Color.'' Seven U.S. health
departments will form, lead, and coordinate a collaborative with 37
community-based organizations (CBOs), clinics and other health
providers, behavioral health and social health providers in their
jurisdictions. The collaborative will report standardized program
monitoring and evaluation (M&E) data to the health department and then
the health department will report the same M&E data to CDC.
DATES: Written comments must be received on or before January 26, 2016.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0107 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of
[[Page 74107]]
Management and Budget (OMB) for each collection of information they
conduct or sponsor. In addition, the PRA also requires Federal agencies
to provide a 60-day notice in the Federal Register concerning each
proposed collection of information, including each new proposed
collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Comprehensive HIV Prevention and Care for Men Who Have Sex With Men
of Color--New--National Center for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Approximately 50,000 people in the United States are newly infected
with HIV each year. Gay, bisexual, and other men who have sex with men
(MSM) remain the US population most heavily affected by HIV infection.
Among MSM, those who are black and Hispanic comprise 58% of all new
infections. To address the burden of HIV in this population, high
impact HIV prevention approaches should be implemented by state, local,
and territorial health departments to reduce new HIV infections among
MSM of color, and to improve outcomes along the HIV continuum of care
for MSM of color living with HIV.
Antiretroviral (ARV) medications for pre-exposure prophylaxis
(PrEP) can be used for HIV prevention by MSM at substantial risk for
HIV acquisition or by those with a possible HIV exposure in the past 72
hours post-exposure prophylaxis (nPEP). The daily use of co-formulated
tenofovir disoproxil fumarate and emtricitabine (marketed as Truvada)
for PrEP has been proven to significantly reduce the risk of HIV
acquisition among sexually active MSM. In July 2012, the US Food and
Drug Administration approved an HIV prevention indication for Truvada,
and in May 2014 CDC published clinical practice guidelines for
provision of PrEP. Given the high incidence of HIV among MSM of color,
those who are sexually active are considered at risk for HIV
acquisition and thus could benefit from prevention services such as
routine and frequent HIV screening with lab-based 4th generation HIV
tests, routine screening for STDs, assessment of PrEP eligibility,
provision of PrEP (if at substantial risk for HIV acquisition),
provision of nPEP (if a possible HIV exposure occurred in the past 72
hours), and/or other risk reduction interventions.
Among people living with HIV (PLWH), ARV treatment can suppress HIV
viral load, which both improves health outcomes of individuals and
reduces the risk of HIV transmission. Two studies, one that
demonstrated the effectiveness of ARV treatment in preventing HIV
transmission, and one that demonstrated improved health outcomes for
individuals whose ARV treatment was initiated immediately, have led to
increased public health focus on interventions and strategies designed
to initiate ARV treatment, link, retain, and re-engage PLWH in HIV
care, and to provide support for adherence to ARV medications.
The purpose of this project is to support state and local health
departments to develop and implement demonstration projects for
provision of comprehensive HIV prevention and care services for MSM of
color by creating a collaborative with CBOs, clinics and other health
care providers, and behavioral health and social services providers in
their jurisdiction. Behavioral health services include mental health
and substance abuse treatment to enable MSM of color to utilize HIV
prevention and care services; social services include services that
promote access to housing, job counseling, and employment services to
enable MSM of color to utilize HIV prevention and care services.
Comprehensive models of HIV prevention and care for MSM of color
will be developed and implemented by a collaborative that is led by the
jurisdiction's health department and includes the following: Health
care providers (e.g., federally qualified health centers (FQHCs), FQHC
Look-Alikes, other clinics, or health care providers); HIV care
providers (e.g., clinics funded through the Ryan White HIV/AIDS Program
(RWHAP clinics), other HIV care clinics, or HIV care providers);
behavioral health and social services providers (i.e., mental health
and substance abuse services, housing programs, and job training or
employment services); and community based organizations (CBOs).
Principles of high impact prevention should guide the selection and
implementation of activities and strategies to focus on MSM of color at
substantial risk for HIV infection (i.e., eligible for prevention with
PrEP), and those living with HIV. MSM of color who are at risk for HIV
acquisition (i.e., sexually active) but not eligible for or decline
PrEP will be provided risk reduction interventions, partner services if
diagnosed with an STD, re-testing for HIV and STDs in 3-6 months, and
behavioral health and social services. The risk of HIV acquisition
should be assessed at every encounter with an individual, and MSM of
color at substantial risk of HIV acquisition should be offered PrEP
when indicated by the risk assessment.
There are a total of 24 required HIV prevention and care services
that must be provided by the health department collaborative for this
project. This is to include thirteen HIV prevention services for MSM of
color at substantial risk for HIV infection and eleven HIV care
services for MSM of color living with HIV infection. The following are
the thirteen HIV prevention services: 1. HIV testing services that use
lab-based 4th generation HIV tests; 2. Assessment of indications for
pre-exposure prophylaxis (PrEP) and non-occupational post- exposure
prophylaxis (nPEP); 3. Provision of PrEP and nPEP; 4. Adherence
interventions for PrEP and nPEP; 5. Immediate linkage to care, ARV
treatment, and partner services for those diagnosed with acute HIV
infection; 6. Expedient linkage to care, ARV treatment, and partner
[[Page 74108]]
services for those diagnosed with established HIV infection; 7. STD
screening and treatment; 8. Partner services for patients with STDs; 9.
Behavioral risk reduction interventions; 10. Screening for behavioral
health and social services' needs; 11. Linkage to behavioral health and
social services; 12. Navigators to assist accessing HIV prevention and
behavioral health and social services; 13. Navigators to assist
enrollment in a health plan. The following are the eleven HIV care
services: 1. HIV primary care, including antiretroviral (ARV)
treatment; 2. Retention interventions; 3. Re-engagement interventions;
4. Adherence interventions; 5. STD screening and treatment; 6. Partner
services; 7. Behavioral risk reduction interventions; 8. Screening
patients for behavioral health and social services' needs; 9. Linkage
to behavioral health and social services; 10. Navigators to assist
linking to care and accessing behavioral health and social services;
11. Navigators to assist enrollment in a health plan.
CDC HIV program grantees will collect, enter or upload, and report
agency-identifying information, budget data, information on the HIV
prevention and care services, and client demographic characteristics
with an estimate of 2,466 burden hours. It is estimated that the 37
respondents will see approximately 200 patients per year. The
respondents will take about 20 minutes to enter the data for each of
the 200 patients using the monitoring and evaluation form.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Health jurisdictions............................ Health Department Collaborative... 37 200 20/60 2,466
--------------------------------------------------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-30130 Filed 11-25-15; 8:45 am]
BILLING CODE 4163-18-P